4Shi Y, Zhang L, Liu X, et al. Icotinib versus gefitinib in previously treated advanced non-small-cell lung (ICOGEN) : a randomised, double-blind phase 3 non-inferiority trial[J]. Lancet Oncol, 2013, 14(10) : 953-961.
5Shaw AT, Solomon BJ. Crizotinib in ROSl-rearranged non-small- cell lung cancer[J]. N Engl J Med, 2015, 372(7) : 683-684.
6Khozin S, Blumenthal GM, Zhang L, et al. FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastie Lymphoma Kinase-Positive Non-Small Cell Lung Cancer[J]. Clin Cancer Res 2015, 21 ( 11 ) : 2436-2439.
7Precision Medicine Initiative in the Offing [ J ]. Cancer Discov, 2015, 5(5) : 456.
8http ://www. fda. gov/downloads/MedicalDevices/Device RegulationandGuidance/GuidanceDocuments/UCM262327. pdf. In.
9http ://www. fda. gov/MedicalDevices/Productsand MedicalProcedures/InVitroDiagnostics/ucm407297. htm. In.
10Li M, Yu T, Hu YF. The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine[J]. Stat Med, 2015, 34(14): 2222-2234.
